Your browser doesn't support javascript.
loading
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
Bruun, Jarle; Sveen, Anita; Barros, Rita; Eide, Peter W; Eilertsen, Ina; Kolberg, Matthias; Pellinen, Teijo; David, Leonor; Svindland, Aud; Kallioniemi, Olli; Guren, Marianne G; Nesbakken, Arild; Almeida, Raquel; Lothe, Ragnhild A.
Afiliação
  • Bruun J; Department of Molecular Oncology, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Sveen A; K.G. Jebsen Colorectal Cancer Research Centre, Clinic for Cancer Medicine, Oslo University Hospital, Norway.
  • Barros R; Department of Molecular Oncology, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Eide PW; K.G. Jebsen Colorectal Cancer Research Centre, Clinic for Cancer Medicine, Oslo University Hospital, Norway.
  • Eilertsen I; Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Portugal.
  • Kolberg M; Instituto de Investigação e InovaçãoemSaúde (i3S), Porto, Portugal.
  • Pellinen T; Faculty of Medicine, University of Porto, Portugal.
  • David L; Department of Molecular Oncology, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Svindland A; K.G. Jebsen Colorectal Cancer Research Centre, Clinic for Cancer Medicine, Oslo University Hospital, Norway.
  • Kallioniemi O; Department of Molecular Oncology, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Guren MG; K.G. Jebsen Colorectal Cancer Research Centre, Clinic for Cancer Medicine, Oslo University Hospital, Norway.
  • Nesbakken A; Department of Molecular Oncology, Institute for Cancer Research, the Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Almeida R; K.G. Jebsen Colorectal Cancer Research Centre, Clinic for Cancer Medicine, Oslo University Hospital, Norway.
  • Lothe RA; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland.
Mol Oncol ; 12(9): 1639-1655, 2018 09.
Article em En | MEDLINE | ID: mdl-29900672
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biomarcadores Tumorais / Fator de Transcrição CDX2 / Testes Farmacogenômicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biomarcadores Tumorais / Fator de Transcrição CDX2 / Testes Farmacogenômicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article